Helixgate https://validator.w3.org/feed/docs/rss2.html Alzheimer’s Linked to Cancer Mutations in Brain Immune Cells RFK Jr. says China is ‘eating our lunch’ in biotech advances Tortugas debuts with $106M and brain drugs from Hansoh, Eisai Merck’s Welireg combo fails in first-line kidney cancer Merck’s fast-ascending kidney cancer drug hits a setback UnitedHealth breaks down how it plans to spend $1.5B on AI Navigating with Excellence: The Multi-Faceted Service Lines of Precision Logistics FDA approves once-daily HIV pill from Merck Flu vaccine no longer mandated for U.S. troops, defense secretary says ‘It’s just the beginning’ for pancreatic cancer’s long-awaited breakthrough STAT+: RFK Jr. to face four GOP doctors at Senate hearings A criminal sentence for OxyContin maker Purdue Pharma clears the way for completing its settlement Replimune cuts will leave over 200 jobless in Massachusetts Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs STAT+: Kelonia Therapeutics’ road from floundering to $3 billion Merck, Eisai’s Keytruda triplet fails to improve survival in kidney cancer AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data Where Utah’s experiment with AI doctors is headed next Gilead, Arcus tumble again in TIGIT, triggering 2 trial culls STAT+: Kennedy hints at coming breakthrough device announcement AACR 2026: A Video Update from San Diego STAT+: BioAge says experimental pill aimed at reducing heart risks significantly reduced inflammation Soleno sold at a discount to Neurocrine due to dwindling European prospects Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine Opinion: What happens when a chief executive loses executive functions? As Duchenne innovation booms, let’s ensure it becomes real progress CleanAssure Launched as an ISO Class 5 Controlled Cleanroom for Sterile Single-Use Assemblies Home Replimmune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection STAT+: At AACR, a provocative use of CAR-T, Merck’s new thing and cancer’s geography problem STAT+: Former banker brought on to revitalize Pfizer’s strategy departs his post Synthetic Biology and Tissue Engineering Grow Liver Tissue In‑Body STAT+: In early trial, CAR-T results raise hope of preventing multiple myeloma in high-risk patients Trump, FDA plan to expedite psychedelic development RFK Jr. defends HHS tenure, 12% proposed budget cut Novartis cuts two programs in cancer-related blood clots Lilly to Acquire Kelonia for Up to $7B, Expanding Cancer Cell Therapy Pipeline STAT+: Trump order to advance psychedelic treatments generates excitement — and worries AACR 2026: Cancers of Unknown Primary Identified by DNA Methylation AI Model Viatris recalls extended-release Xanax over dissolution test failure Nektar surges again as alopecia drug shows new promise in extension study Merck partner reveals bispecific data; Biogen pays $100M for antibody rights STAT+: The PBMs fight back, and arbitration doesn’t lose Boehringer Ingelheim to expand its AI footprint in UK, in £150M investment Biotech has become a good news story. Let the sun shine Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal Agenus cancer cocktail records 0% response rate, missing midstage goal Novo’s late-stage sickle cell win piles pressure on competitors STAT+: Finally cracking KRAS as a druggable target Lilly to buy Kelonia for $3.25B upfront, underlining its in vivo CAR-T strategy